CSPC Pharmaceutical Group revenue and financials

1093 · HKEX · HKD

$9.86−1.40%−$0.14

Close · October 7, 2026

In the fiscal year ended December 2025, CSPC Pharmaceutical Group reported revenue of ¥26.01B (−10.35% year over year). Net income was ¥3.88B, a net margin of 14.9%.

Annual revenue · 2025: ¥26.01B
  1. ¥30.94B2022
  2. ¥31.45B2023
  3. ¥29.01B2024
  4. ¥26.01B2025

Fiscal year ending in December. Sources and method on the page Methodology and sources.

At a glance

Revenue growth
−10.35%
2025 vs 2024
Net income growth
−10.30%
2025 vs 2024
Net margin
14.9%
2024: 14.9%

Financial data

Amounts in millions of CNY; per-share values in CNY; shares in millions.

ItemQ1 2026Q1 2025
Basic EPS0.080.13
Diluted EPS0.080.13
Average shares (basic)11,40311,448
Average shares (diluted)11,40311,448